Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0369-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0368-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0367-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0366-2019Class IIOngoingJan 23, 2019Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0365-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 10 mg/320 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0364-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 5 mg/320 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0363-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 10 mg/160 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0362-2019Class IIOngoingJan 23, 2019Amlodipine and Valsartan Tablets USP 5 mg/160 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0361-2019Class IICompletedJan 16, 2019OZURDEXGMP Deviations: A silicone particulate was noted in Ozurdex.Allergan, PLC. · D-0387-2019Class IITerminatedJan 16, 2019Cefdinir for Oral Suspension USPCGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.Lupin Pharmaceuticals Inc. · D-0376-2019Class IITerminatedJan 16, 2019Cefdinir for Oral Suspension USPCGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.Lupin Pharmaceuticals Inc. · D-0375-2019Class IITerminatedJan 16, 20190.9% Buffered Lidocaine HClSubpotentPharMEDium Services, LLC. · D-0374-2019Class ITerminatedJan 16, 2019Vecuronium Bromide for Injection 20 mg* *1mg/mL when reconstituted to 20 mL LyophilizedPresence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.Sun Pharmaceutical Industries, Inc. · D-0373-2019Class ITerminatedJan 16, 2019Vecuronium Bromide for Injection 10 mg*Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.Sun Pharmaceutical Industries, Inc. · D-0372-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0358-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0357-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0356-2019Class ITerminatedJan 16, 2019Ceftriaxone for Injection USPPresence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted...Lupin Pharmaceuticals Inc. · D-0355-2019Class IITerminatedJan 16, 2019Cidofovir Injection 375mg/5mLLack of Assurance of Sterility: complaints received about dried powder on the outside of bottleHeritage Pharmaceuticals, Inc. · D-0352-2019Class IITerminatedJan 16, 2019Dianeal Low CalciumLack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.Baxter Healthcare Corporation · D-0351-2019Class IITerminatedJan 16, 2019Estradiol Vaginal InsertsDefective Delivery System: Customer complaints of malfunctioning plunger of the applicatorGlenmark Pharmaceuticals Inc., USA · D-0350-2019Class IITerminatedJan 9, 2019Lidocaine gel 1%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0408-2019Class IITerminatedJan 9, 2019Glutathione liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0407-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.05%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0406-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0405-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 0.5%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0404-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 1%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0403-2019Class IITerminatedJan 9, 2019Vitamin B12 liquid 1000mcg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0402-2019Class IITerminatedJan 9, 2019Testosteron Cypionate liquid 200mg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0401-2019Class IITerminatedJan 9, 2019Methocarbamol liquid 100mg/mlLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0400-2019Class IITerminatedJan 9, 2019MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vialLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0399-2019Class IITerminatedJan 9, 2019Lidocaine/Epinepherine liquid 1%/ 1:1000Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0398-2019Class IITerminatedJan 9, 2019Lidocaine gel 2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0397-2019Class IITerminatedJan 9, 2019Hydroxyprogesterone liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0396-2019Class IITerminatedJan 9, 2019HCG liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0395-2019Class IITerminatedJan 9, 2019Glutathione liquidLack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0394-2019Class IITerminatedJan 9, 2019Epinephrine liquid 1:1000Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0393-2019Class IITerminatedJan 9, 2019Cyclosporin liquid 2%Lack of sterility assurance.Hiers Enterprises, LLC dba Northwest Compounding Pharmacy · D-0392-2019Class IITerminatedJan 9, 2019Nitrofurantoin Oral SuspensionSubpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.Lupin Somerset · D-0346-2019